Literature DB >> 16047310

Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.

Sang Yun Cho1, Eun-Young Lee, Joon Seok Lee, Hye-Young Kim, Jae Myun Park, Min-Seok Kwon, Young-Kew Park, Hyoung-Joo Lee, Min-Jung Kang, Jin Young Kim, Jong Shin Yoo, Sung Jin Park, Jin Won Cho, Hyon-Suk Kim, Young-Ki Paik.   

Abstract

Human plasma is the most clinically valuable specimen, containing not only a dynamic concentration range of protein components, but also several groups of high-abundance proteins that seriously interfere with the detection of low-abundance potential biomarker proteins. To establish a high-throughput method for efficient depletion of high-abundance proteins and subsequent fractionation, prior to molecular analysis of proteins, we explored how coupled immunoaffinity columns, commercially available as multiple affinity removal columns (MARC) and free flow electrophoresis (FFE), could apply to the HUPO plasma proteome project. Here we report identification of proteins and construction of a human plasma 2-DE map devoid of six major abundance proteins (albumin, transferrin, IgG, IgA, haptoglobin, and antitrypsin) using MARC. The proteins were identified by PMF, matching with various internal 2-DE maps, resulting in a total of 144 nonredundant proteins that were identified from 398 spots. Tissue plasminogen activator, usually present at 10-60 ng/mL plasma, was also identified, indicative of a potentially low-abundance biomarker. Comparison of representative 2-D gel images of three ethnic groups (Caucasian, Asian-American, African-American) plasma exhibited minor differences in certain proteins between races and sample pretreatment. To establish a throughput fractionation of plasma samples by FFE, either MARC flow-through fractions or untreated samples of Korean serum were subjected to FFE. After separation of samples on FFE, an aliquot of each fraction was analyzed by 1-D gel, in which MARC separation was a prerequisite for FFE work. Thus, a working scheme of MARC --> FFE --> 1-D PAGE --> 2-D-nanoLC-MS/MS may be considered as a widely applicable standard platform technology for fractionation of complex samples like plasma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047310     DOI: 10.1002/pmic.200401310

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  22 in total

1.  Protein separation and characterization by np-RP-HPLC followed by intact MALDI-TOF mass spectrometry and peptide mass mapping analyses.

Authors:  Claire Dauly; David H Perlman; Catherine E Costello; Mark E McComb
Journal:  J Proteome Res       Date:  2006-07       Impact factor: 4.466

Review 2.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

3.  Novel Sample Preparation for Mass Spectral Analysis of Complex Biological Samples.

Authors:  Eric A Porsch; Cecelia A Shertz; Michael D Boyle
Journal:  Curr Proteomics       Date:  2010-07       Impact factor: 0.837

4.  Identification of EBP50 as a specific biomarker for carcinogens via the analysis of mouse lymphoma cellular proteome.

Authors:  Yoen Jung Lee; In-Kwon Choi; Yhun Yhong Sheen; Sue Nie Park; Ho Jeong Kwon
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 5.  Multi-dimensional liquid chromatography in proteomics--a review.

Authors:  Xiang Zhang; Aiqin Fang; Catherine P Riley; Mu Wang; Fred E Regnier; Charles Buck
Journal:  Anal Chim Acta       Date:  2010-02-06       Impact factor: 6.558

Review 6.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

7.  Moesin is a biomarker for the assessment of genotoxic carcinogens in mouse lymphoma.

Authors:  Yoen Jung Lee; In-Kwon Choi; Yhun Yhong Sheen; Sue Nie Park; Ho Jeong Kwon
Journal:  Mol Cells       Date:  2012-01-26       Impact factor: 5.034

8.  Proteomic analysis of sera of asymptomatic, early-stage patients with Wilson's disease.

Authors:  Jung-Young Park; Joo Hee Mun; Beom Hee Lee; Sun Hee Heo; Gu-Hwan Kim; Han-Wook Yoo
Journal:  Proteomics Clin Appl       Date:  2009-10       Impact factor: 3.494

9.  Gene network and canonical pathway analysis in prostate cancer: a microarray study.

Authors:  Hakan Savli; Attila Szendröi; Imre Romics; Balint Nagy
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

10.  Application of free-flow electrophoresis/2-dimentional gel electrophoresis for fractionation and characterization of native proteome of Pseudomonas putida KT2440.

Authors:  Chi-Won Choi; Young S Hong; Seung Il Kim
Journal:  J Microbiol       Date:  2008-08-31       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.